SGP - Spyglass Pharma, Inc.

Insider Purchase by Chang Carmen (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Chang Carmen, serving as 10% owner at Spyglass Pharma, Inc. (SGP), purchased 937,500 shares at $16.00 per share, for a total transaction value of $15,000,000.00. Following this transaction, Chang Carmen now holds 7,392,301 shares of SGP.

This purchase represents a 15.00% increase in Chang Carmen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.

Chang Carmen

Chang Carmen

10%

Carmen Chang is a prominent venture capital investor and 10% owner of SpyGlass Pharma, Inc. (SGP), holding approximately 7,392,301 shares valued at over $205 million as of recent filings.[[1]](https://www.gurufocus.com/insider/48650/carmen-chang)[[4]](https://www.stocktitan.net/sec-filings/SGP/schedule-13d-spy-glass-pharma-inc-major-shareholder-acquisition-5-8739c900d44e.html) She recently participated in a significant share purchase on February 9, 2026, acquiring shares at $16 each alongside other insiders and executives, signaling strong confidence in the company's future.[[3]](https://www.ainvest.com/news/spyglass-pharma-director-khan-bilal-arshad-buys-115000-shares-16-share-2602/)[[7]](https://whalewisdom.com/filing/chang-carmen-4-2026-02-11-163006-0500-sgp)[[8]](https://www.tipranks.com/news/insider-trading/spyglass-pharma-insiders-make-a-massive-high-stakes-bet-on-the-companys-future-insider-trading) Chang serves as a manager of general partner entities associated with her investments and maintains substantial stakes across multiple biotech firms, including Mirum Pharmaceuticals Inc. (MIRM) with 4,186,243 shares worth $188 million, Savara Inc. (SVRA) with 24,471,264 shares worth $75 million, and Trevi Therapeutics Inc. (TRVI) with 11,370,376 shares.[[1]](https://www.gurufocus.com/insider/48650/carmen-chang) Her portfolio spans 15 companies, such as Akouos Inc., MBX Biosciences Inc., and Coursera Inc., with her estimated net worth exceeding $478 million as of 2025.[[1]](https://www.gurufocus.com/insider/48650/carmen-chang) SEC filings confirm her role as a 10% owner in SpyGlass Pharma through beneficial ownership structures.[[5]](https://insiderinsights.com/free/index.php?s=ticker&o=-1&a=&q=SGP)[[6]](https://www.stocktitan.net/sec-filings/SGP/form-3-spy-glass-pharma-inc-initial-statement-of-beneficial-ownership-b62511ac8776.html)

View full insider profile →

Trade Price

$16.00

Quantity

937,500

Total Value

$15,000,000.00

Shares Owned

7,392,301

Trade Date

Monday, February 9, 2026

13 days ago

SEC Filing Date

Wednesday, February 11, 2026

Filed 2 days after trade

About Spyglass Pharma, Inc.

Company Overview

No company information available
View news mentioning SGP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3898259

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime